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Transmissible spongiform encephalopathies (TSE) are fatal neurodegenerative disorders characterized by the conversion of the normal
prion protein (PrPC) into aggregates of its pathological conformer (PrPSc). The mechanism behind this structural conversion is unclear. We
report the identification of disease-related protein structural differences directly within the tissue environment. Utilizing a synchrotron
infrared (IR) light source, IR images of protein structure were obtained at a subcellular resolution, revealing regions of decreased a-helical
content and elevated h-sheet structure in and around infected neurons in the 263 K scrapie hamster model. PrPSc immunostaining of the same
tissue demonstrated that the elevated h-sheet regions correspond to regions where the misfolded structure of PrPSc is located. No evidence of
these structural changes was observed in normal neurons.
D 2003 Elsevier B.V. All rights reserved.Keywords: Prion; Transmissible spongiform encephalopathy (TSE); 263 K scrapie; Synchrotron fourier-transform infrared (FTIR) microspectroscopy; Dorsal
root ganglion; Syrian hamster
Sc1. Introduction
Transmissible spongiform encephalopathies (TSE) such
as scrapie, bovine spongiform encephalopathy, and Creutz-
feldt–Jakob disease are fatal disorders affecting the brain
and other parts of the nervous system [1]. They can be
identified by accumulations of the pathological form of a
cellular protein, the prion protein (PrP). The pathogenesis of
the disease apparently involves a structural change of PrP,
resulting in misfolded aggregates (PrPSc) [2], which accu-
mulate at the plasmalemma [3], and also in Golgi and in-
tracytoplasmic organelles of neurons [4]. Although a protein
conformational change evidently plays a role in the disease
process, the mechanism behind this process is unclear.0925-4439/$ - see front matter D 2003 Elsevier B.V. All rights reserved.
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* Corresponding authors. Janina Kneipp is to be contacted at 221 Hoyt
Laboratory, Chemistry Department, Princeton University, Princeton, NJ
08544, USA. Tel.: +1-609-258-3908; fax: +1-609-258-3890. Dieter
Naumann. Tel.: +49-30-4547-2259; fax: +49-30-4547-2606.
E-mail addresses: jkneipp@princeton.edu (J. Kneipp),
naumannd@rki.de (D. Naumann).Antibody labeling is used to detect PrP in tissue, but
does not provide direct information on the target protein’s
structure [5,6], and to date only few conformation-specific
antibodies with limited applicability to histology have been
found [7,8]. It is well established that Fourier-transform
infrared (FTIR) spectroscopy is an excellent method for
determining protein secondary structure in solution [9,10].
FTIR spectroscopy and circular dichroism have demonstrat-
ed that the structure of PrPSc is relatively rich in h-sheet
content as compared to the normal, cellular isoform PrPC in
solution [11–14]. The same principles that apply for pro-
teins in solution can be used to determine protein secondary
structure within tissue. An infrared (IR) microscope is used
to focus the IR light onto a small area of tissue and the
absorbance is determined as a function of wavelength. By
translating the sample in a grid-like pattern through the
beam, an IR image of protein secondary structure can be
generated.
The size of the misfolded aggregates varies for different
TSE strains and disease stages. In the TSE strain used in our
study, the aggregates range from micro-disperse to a few
J. Kneipp et al. / Biochimica et Biophysica Acta 1639 (2003) 152–158 153microns in size. Therefore, subcellular resolution is required
to determine the structure of the PrPSc aggregates, which is a
resolution that approaches the diffraction limit of IR light
(f 6 Am at 1650 cm 1) and can only be achieved using a
synchrotron IR source [15,16]. In previous imaging studies
using a conventional IR source with a spatial resolution of
30–50 Am, we observed spectral changes in infected tissue
even in early disease stages [17], but we did not observe
PrPSc-specific changes in protein structure [18]. Since PrPSc
accounts for only 0.1% of all proteins in the diseased brain
tissue in the terminal stage of the disease [19], we concluded
that any changes in PrP secondary structure were likely
obscured by changes of much greater magnitude occurring
in other proteins in the tissue due to the pathological
process.
In this work, we imaged protein structural variations in
individual neurons from the dorsal root ganglia of 263 K
scrapie-infected Syrian hamsters using synchrotron-based
IR microspectroscopic imaging. The high brilliance of the
light source permitted subcellular spatial resolution (f 6
Am). After the IR measurements, PrP immunostaining was
used to correlate the distribution of these protein structure
alterations with the presence of PrPSc.2. Materials and methods
2.1. Animal experiments and sample preparation
All animal experiments were carried out in accordance
with European and German legal and ethical regulations.
Two female Syrian hamsters infected orally with 100 Al of a
10% 263 K hamster scrapie brain homogenate (cor-
responding to 1–3 107 50% intracerebral lethal doses
(LD50i.c.)) as described elsewhere [20] were sacrificed with
CO2 in the terminal stage of the disease (162 days after
inoculation). An uninfected animal served as control. Cervi-
cal and thoracic dorsal root ganglia were removed and stored
at  70 jC. Sequential cryo-sections of 14-Am thickness
were cut; adjacent sections were mounted on a CaF2 slide (1
mm in thickness) for IR imaging and on a standard micro-
scope slide for histological staining, respectively. Slides were
kept in a dry environment until the IR measurements were
carried out.
2.2. Experimental setup and acquisition of FTIR data
Infrared images were collected at beamline U10B at the
National Synchrotron Light Source, Brookhaven National
Laboratory, Upton, NY [15]. Synchrotron light was used as
a light source for a Nicolet Magna 860 spectrometer
(ThermoNicolet, Madison, WI), which was coupled to a
Continuum IR microscope (SpectraTech, ThermoNicolet).
The microscope was equipped with an MCT-A detector, an
adjustable rectangular aperture, matching 32 Schwarz-
schild objectives, and a motorized stage. Absorbance spectrawere acquired in transmission mode from the samples in the
spectral range from 4000 to 650 cm 1 at 8 cm 1 spectral
resolution using the Omnic 5.2a software (ThermoNicolet).
Happ–Genzel apodization and a zero filling level of 2 were
applied, yielding an interval of approximately one data point
per wavenumber. The number of co-added interferograms
per spectrum was set to 256. The size of the aperture was
chosen to be 10 10 Am2. The signal-to-noise ratio for
these settings was approximately 600 in the amide I spectral
region (as determined from first derivatives). All spectra
were collected by raster scanning with a step width of 4 Am
in predefined grids containing one or two single cells.
Approximately four to five neurons were chosen randomly
from each ganglion for the measurements. Altogether, 31
neurons from infected ganglia and 32 neurons from unin-
fected ganglia were investigated, yielding approximately
5000 pixel spectra.
2.3. Analysis of the spectra
From all spectra, the following parameters were deter-
mined and used for the construction of IR images: (i)
characteristic frequency of the amide I band in the original
spectra, (ii) ratio of the intensities of the a-helical and h-
sheet components of the amide I band (determined from the
second derivatives of the original spectra), and (iii) results of
hierarchical cluster analyses using the information in the
amide I spectral region (1600–1700 cm 1) in the original
spectra of each data set. All images were constructed by
plotting the characteristic frequency, intensity ratio or clas-
sification result as a function of the lateral coordinates of the
corresponding spectrum as contour plots using Origin 6.1
(OriginLab, Northhampton, MA).
The peak positions of the amide I and amide II absorp-
tion bands were read out from all spectra of the data sets
using the OPUS 3.01 software (Bruker, Ettlingen, Ger-
many). The ratio of the intensities of the a-helical and h-
sheet components was determined from second derivatives
of the spectra, which were calculated applying a Savitzky–
Golay algorithm with 9 smoothing points. The spectra were
vector-normalized over the frequency range 1700–1500
cm 1 and the ratio of the intensities at 1637 and 1657
cm 1 (I1637/I1657) was determined. Due to the fact that
absorbance and full width at half height (FWHH) are
inversely interrelated to the third power in second order
derivatives, peak height in second derivative spectra is very
sensitive to changes of FWHH of the IR band. However,
cells and tissues are composed of similar substances, caus-
ing broad and superimposed IR bands. We therefore as-
sumed that the FWHH does not exhibit significant changes
over certain cellular structures and used second order
derivative spectra as concentration-sensitive measures.
Hierarchical cluster analysis was carried out on original
spectra from each data set using CytoSpec (http://www.
cytospec.com). Spectral distances were calculated between
pairs of spectra as Pearson’s correlation coefficients as
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for hierarchical clustering. Each spectrum of a specific
spectral class was assigned the same gray value, and this
gray value was plotted as a function of the lateral
coordinates.
2.4. Immunostaining of the samples
After the IR imaging, all sections were stained by
immunocytochemistry for the prion protein PrP. In some
samples, the sections adjacent (10 Am apart) to those used
for the IR measurements were used. Immunostaining was
done with the monoclonal antibody (mAb) 3F4 [22] from
cell culture (1.4 Ag/ml, 1:100) (a kind gift of Hans Huser,
Robert-Koch-Institut, Berlin, Germany), as described previ-
ously [17]. Biotinylated goat anti-mouse antibody (DAKO
Diagnostika, Hamburg, Germany), peroxidase-conjugated
Vectastain ABC Kit (Vector Laboratories, Burlingame,
CA), and 3,3V-diaminobenzidine as a substrate were used
for detection of bound mAb 3F4. All sections were counter-
stained with hematoxylin. In order to meet the technical
requirements for the IR measurements, the cryo-sections,
which were kept in dry environment at room temperature,
were used for immunostaining. Despite the known difficul-
ties in connection with the usage of cryo-cut instead of
paraffin-embedded material for this purpose, immunocyto-
chemical staining could be performed at reasonable quality.
In some sections, slight displacement of tissue occurred due
to insufficient fixation on the CaF2 crystals that were used
for the IR measurements (see, e.g. Fig. 4B).3. Results
Protein structure was imaged in individual neurons from
the dorsal root ganglia of 263 K scrapie-infected SyrianFig. 1. Dorsal root ganglion of a Syrian hamster. (A) Hematoxylin–eosin stained
smaller satellite cells (st). Nerve fibers (nf) are leading into and out of the ganglio
single neurons as viewed through the IR microscope. The frame depicts the areahamsters. Thoracic and cervical dorsal root ganglia of
scrapie-infected and uninfected (control) hamsters were
cryo-cut and dried (see Section 2) and the unstained sections
were investigated using synchrotron-based IR microspectro-
scopic imaging. The measurements were carried out on 31
single neurons from the infected ganglia and on 32 neurons
from the uninfected ganglia. Each data set, comprising the
area of one or two neurons, contained 80–180 IR spectra.
Fig. 1A displays a hematoxylin–eosin (H&E)-stained
section of a dorsal root ganglion of a healthy hamster. The
single, large neurons can clearly be distinguished from the
surrounding, smaller satellite cells and from the nerve fibers
leading into and out of the ganglion. Comparison with the
adjacent section (Fig. 1B) shows that the cells can also be
distinguished in the unstained tissue used for IR imaging.
These qualities make dorsal root ganglia a very suitable
system for microspectroscopic studies on the cellular and
subcellular level without detailed assignment of spectra
from specific tissue structures [17,18].
3.1. Altered protein structure distribution in single neurons
The energy of IR light that is absorbed by a protein is
dependent upon the alignment of the amide bonds in the
protein backbone. Thus, different secondary structural ele-
ments, such as a-helix, triple helix, h-sheet, h-turn, and
extended coil, absorb IR light at different wavelengths in
the so-called amide I region [9]. Expressed in terms of
frequency (or energy), this region of the IR spectrum is
located between 1600 and 1700 cm 1. The amide I region
was used to investigate protein secondary structure within
the nervous tissue. IR images of each neuron were gener-
ated by collecting individual IR spectra point by point in a
raster-scan format using the IR microscope. For each
spectrum (i.e. pixel) of the image, the amide I (1600–
1700 cm 1) absorption region was analyzed to assesssection, the large neurons (n) can be distinguished from the surrounding,
n. Scale bar: 100 Am. (B) Adjacent, unstained section, magnification of two
of an IR imaging experiment carried out on this section (96 48 Am).
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neuron. Fig. 2A displays typical IR absorbance spectra
from different regions of both scrapie-infected and control
neurons. A shift of the amide bands can be seen in some,
but not all, spectra from the scrapie-infected ganglia. The
spectra from the infected ganglia displaying the band shift
are shown in blue; those showing no different band position
as compared to spectra from healthy ganglia are shown in
red (solid lines in Fig. 2A). The shift was not observed in
any of the spectra from the control ganglia (see dashed red
lines in Fig. 2A).
At each pixel in the image, the frequency position of the
amide I absorption maximum was determined and a ‘fre-
quency map’ of a neuron was generated. Fig. 2B and C
displays such maps for some examples from scrapie-
infected and control ganglia, respectively. While the char-
acteristic amide I frequency varied between 1658 and 1654
cm 1 in the normal ganglia (Fig. 2C), approximately 15%
of the spectra in 10 of the 31 maps obtained from scrapie
ganglia displayed a shift of the amide I band of approxi-
mately 10 cm 1, resulting in an absorption maximum at
1645 cm 1 (Fig. 2A).Fig. 2. Absorbance spectra and amide I frequency maps from scrapie-infected an
different regions in a neuron from an infected ganglion (solid lines, red and blue) a
be observed in some of the spectra from the scrapie neuron (blue spectra). (B and
maps were constructed by plotting the characteristic frequency of the amide I b
insufficient quality, which were excluded from the analysis. Each map comprises
from a measurement that had to be terminated early for technical reasons. (D) S
infected ganglion. The colors of the spectra correspond to the regions shown in the
with an inset depicting the area of measurement is shown below.To better estimate the contributions of the different
secondary structure elements to the observed shift of the
amide I maximum, second derivatives of the spectra were
analyzed (Fig. 2D). The second derivatives show that the
shift of the amide I band maximum to lower wavenumbers
(Fig. 2A) is caused by two factors, namely an increased
intensity of the h-sheet band at 1637 cm 1, together with
the appearance of a new component at 1631 cm 1 in some
spectra, and a frequency shift of the a-helix band at 1657 to
1650 cm 1 (blue spectra in Fig. 2D). The ratio of the bands
representing h-sheet and a-helical structures (I1637 cm 1/
I1657 cm 1) was calculated for all spectra (Fig. 2D). The
resulting images correlated well with the amide I frequency
maps (Fig. 3C) and demonstrate that many, but not all,
scrapie-infected neurons contain regions of elevated h-sheet
structure content.
As can be seen from the IR images, there is considerable
variation in protein structure only throughout neurons of
infected ganglions. An objective examination of this vari-
ability was obtained by applying a hierarchical cluster
analysis to each IR data set, based on the spectral distances
which were calculated between pairs of spectra as Pearson’sd control ganglia. (A) Absorbance spectra (vector-normalized) representing
nd from a control ganglion (red dashed line). A shift of the amide I band can
C) Frequency maps from scrapie-infected (B) and control (C) ganglia. The
and as a function of pixel location. The black pixels indicate spectra of
a single neuron (compare (D)). The uppermost right map in (B) originates
econd derivatives of spectra from different regions in a nerve cell from an
intensity ratio map on the left. A photomicrograph of the unstained section
Fig. 3. Result of a cluster analysis applied to one spectral data set from a scrapie-infected ganglion (from Fig. 2D), based on the spectral distances
(calculated between pairs of spectra as Pearson’s correlation coefficients) over the range of 1600–1700 cm 1 (amide I). (A) The dendrogram displays
separation into two major classes. (B) Pattern-based image, reconstructed from the result of the cluster analysis. Each pixel in the image corresponds to one
spectrum in the data set. The two classes are shown in gray and white, respectively. (C) Position of the amide I absorption maximum plotted as a function of
each pixel position.
Fig. 4. Photomicrographs of three immunostained sections. (A) Immunos-
taining result for a section from a scrapie-infected dorsal root ganglion.
Pathological PrP can be detected as brown accumulations of granular
structures in many neurons, whereas some cells remain unstained. Scale
bar: 25 Am. (B and C) Immunostaining results for one of the examples
shown in Fig. 2B (second image) and for the example displayed in Fig. 3.
The areas of the measurements are indicated and the amide I frequency
maps are shown for comparison. Scale bars: 20 Am.
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1700 cm 1). All analyses yielded the formation of distinct
spectral clusters, suggesting the existence of considerable
spectral heterogeneity within the infected nerve cells. In
almost one third of the measurements on scrapie-affected
ganglia, one group of spectra clearly separated from the rest
of the data set. A typical result is visualized in the dendro-
gram of Fig. 3A. For each measurement, the clusters were
assigned different gray values, and new IR images were
generated based on the different clusters. Fig. 3B shows the
cluster analysis-based image derived from the dendrogram of
Fig. 3A. When systematically comparing the cluster analysis
images with the amide I frequency images, we found that the
uniquely separated cluster co-localized with the shift of the
amide I band to lower frequencies (Fig. 3C).
3.2. Structure correlation with PrPSc immunostaining
In order to correlate the structural information obtained
from the IR images with the location of PrPSc aggregates,
immunostaining was performed with the 3F4 antibody for
PrP. As can be seen in Fig. 4A, some cells from ganglia of
the terminally diseased animals stained heavily for PrPSc,
whereas others did not. Comparison of the staining results
with the IR images revealed that all cells exhibiting spectral
changes consistent with increased h-sheet formation were
also found to co-localize with a more intense staining for
PrP (see examples in Fig. 4B and C). However, not all
neurons that stained positive for PrPSc with the antibody
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structure in the IR mapping experiment (only in 10 of 31
nerve cells changes in protein structure were indicated by IR
spectroscopy). This is very likely a problem of actual local
PrPSc concentration, probably determined by the size and
density of the aggregates: the IR absorption characteristics
of the PrPSc aggregates are averaged with the absorption of
all other protein molecules and, similar to a dilution effect,
no longer detected if they are too small.4. Discussion
The results of this work demonstrate that changes of
protein secondary structure can be investigated in situ in
individual neurons of dorsal root ganglia. The structure-
sensitive amide I region of the IR microspectra measured at
subcellular spatial resolution revealed that there exist
regions with altered protein secondary structure in scrapie-
infected nervous tissue.
More specifically, the IR maps in the ganglion sections of
scrapie-infected hamsters provided clear evidence that there
exist cellular regions of increased h-sheet content. These
changes were not observed in any of the images from the
control ganglion cells, strongly suggesting that they are
related to the disease process in the nervous tissue. Analysis
of the fine structure of the spectra showed that the observed
shift of the amide I absorption maximum (Fig. 2A) was
produced by a higher intensity of the h-sheet band at 1637
cm 1, and the appearance of a new band component at 1631
cm 1 in some spectra (Fig. 2D). The appearance of the band
at 1631 cm 1 is indicative of h-sheets with strong hydrogen
bonds as typical for PrPSc or PrPres aggregates isolated from
CNS-material of scrapie-infected hamsters [11]. A similar
shift of the amide I maximum to 1631 cm 1 was also
observed in IR spectra of the much larger Alzheimer’s
neuritic plaques [23], which are known to consist of h-sheet
aggregates [24].
The fact that some cells in the diseased ganglia stained
heavily for PrPSc when treated with the 3F4 anti-PrP anti-
body while others remained unstained (Fig. 4A) is consistent
with the observation that PrPSc aggregates accumulate at
many neurons of dorsal root ganglia during the course of the
disease, while a number of nerve cells of the same ganglion
do not exhibit PrPSc accumulations [25]. Furthermore, com-
parison of the stained sections with the IR images revealed
that all cells exhibiting spectral changes consistent with
increased h-sheet formation were also found to co-localize
with a more intense staining for PrP (Fig. 4B and C). Thus,
the interesting question regarding the prominent structural
differences between the cellular and the misfolded prion
protein is highlighted by the present in situ approach.
Furthermore, most regions in which the spectral alterations
were observed seem to be localized at the cell membranes.
This observation is in agreement with studies that showed
accumulation of PrPSc at the plasmalemma [3,26].The results of this investigation demonstrate that the
misfolding of the PrP protein in scrapie-infected nerve
ganglia results in a relative decrease in a-helical content
concomitant with an increase in h-sheet conformation.
Because the tissue material consists of thousands of
proteinaceous compounds, it is not possible with any
currently available method to find out whether the changed
spectra observed represent the ‘‘pure’’ PrPSc conformation,
or whether they are only partly due to misfolded prion
protein that is present in varying proportions. Certainly,
other cellular changes that may be stimulated by the
presence of PrPSc could also contribute to the observed
spectral changes. These include possible alterations in the
protein environment of PrPSc. However, the h-sheet-spe-
cific spectral features and their co-localization with the PrP
specific antibody labeling suggest that they are a direct
result of PrP structure conversion. Although it cannot be
excluded in principle, evidence of TSE-induced conforma-
tional change in favor of h-sheet structures in other
proteins than PrP itself has not been reported so far in
the numerous studies on these diseases. To further eluci-
date the precise origin of the observed changes in protein
structure, in situ IR studies on other TSE strains displaying
formation of plaque-like PrPSc aggregates, such as BSE in
hamsters, are planned. These experiments will yield spectra
taken at the highest possible concentration of PrPSc in situ
and could be used to model spectra of lower PrPSc
concentrations in other TSE strains. A future experiment
that would allow both quantification of PrPSc and the
simultaneous investigation of protein secondary structure
by IR microspectroscopy could be the application of an
IR-based immunoassay with IR-active labels as proposed
for other applications [27–29]. Ideally, such labels should
be conjugated to an anti-PrP antibody that is conformation-
sensitive to PrPSc, so that the detection of misfolded PrP
could be directly related to structural changes revealed by
the IR spectra.Acknowledgements
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